Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Am J Hypertens. 2018 Apr 13;31(5):541-548. doi: 10.1093/ajh/hpy004.
Left ventricular hypertrophy assessed by electrocardiography (ECG-LVH) is a marker of subclinical cardiac damage and a strong predictor of cardiovascular disease (CVD) events. The prevalence of ECG-LVH is increased in obesity and type 2 diabetes; however, there are no data on the long-term effects of weight loss on ECG-LVH. The purpose of this study was to determine whether an intensive lifestyle intervention (ILI) reduces ECG-LVH in overweight and obese adults with type 2 diabetes.
Data from 4,790 Look AHEAD participants (mean age: 58.8 ± 6.8 years, 63.2% White) who were randomized to a 10-year ILI (n = 2,406) or diabetes support and education (DSE, n = 2,384) were included. ECG-LVH defined by Cornell voltage criteria was assessed every 2 years. Longitudinal logistic regression analysis with generalized estimation equations and linear mixed models were used to compare the prevalence of ECG-LVH and changes in absolute Cornell voltage over time between intervention groups, with tests of interactions by sex, race/ethnicity, and baseline CVD status.
The prevalence of ECG-LVH at baseline was 5.2% in the DSE group and 5.0% in the ILI group (P = 0.74). Over a median 9.5 years of follow-up, prevalent ECG-LVH increased similarly in both groups (odds ratio: 1.02, 95% confidence interval: 0.83-1.25; group × time interaction, P = 0.49). Increases in Cornell voltage during follow-up were also similar between intervention groups (group × time interaction, P = 0.57). Intervention effects were generally similar between subgroups of interest.
The Look AHEAD long-term lifestyle intervention does not significantly lower ECG-LVH in overweight and obese adults with type 2 diabetes.
Trial Number NCT00017953 (ClinicalTrials.gov).
心电图(ECG-LVH)评估的左心室肥厚是亚临床心脏损伤的标志物,也是心血管疾病(CVD)事件的强有力预测因子。肥胖和 2 型糖尿病患者的 ECG-LVH 患病率增加;然而,关于减肥对 ECG-LVH 的长期影响尚无数据。本研究旨在确定强化生活方式干预(ILI)是否可降低超重和肥胖 2 型糖尿病患者的 ECG-LVH。
共纳入 4790 名 LOOK AHEAD 参与者的数据(平均年龄:58.8 ± 6.8 岁,63.2%为白人),这些参与者被随机分配至为期 10 年的 ILI(n = 2406)或糖尿病支持和教育(DSE,n = 2384)组。每 2 年评估一次根据 Cornell 电压标准定义的 ECG-LVH。采用广义估计方程和线性混合模型进行纵向逻辑回归分析,比较干预组之间 ECG-LVH 的患病率和绝对 Cornell 电压随时间的变化,并通过性别、种族/民族和基线 CVD 状态进行交互作用检验。
DSE 组基线时 ECG-LVH 的患病率为 5.2%,ILI 组为 5.0%(P = 0.74)。在中位随访 9.5 年后,两组中 ECG-LVH 的患病率均相似增加(比值比:1.02,95%置信区间:0.83-1.25;组×时间交互作用,P = 0.49)。在随访期间,Cornell 电压的增加也在两组中相似(组×时间交互作用,P = 0.57)。干预效果在感兴趣的亚组之间基本相似。
LOOK AHEAD 长期生活方式干预并不能显著降低超重和肥胖 2 型糖尿病患者的 ECG-LVH。
试验编号 NCT00017953(ClinicalTrials.gov)。